M. B. Yilmaz, Pazarbasi, A., Guzel, A. I., Kocaturk-Sel, S., Kasap, H., Kasap, M., Urunsak, I. F., Basaran, S., Alptekin, D., and Demirhan, O.,
“Association of serum sex steroid levels and bone mineral density with CYP17 and CYP19 gene polymorphisms in postmenopausal women in Turkey”, vol. 10, pp. 1999-2008, 2011.
Many clinical conditions, including osteoporosis, are associated with serum levels of sex steroids. Enzymes that regulate rate-limiting steps of steroidogenic pathways, such as CYP17 and CYP19, are also regarded as significant factors that may cause the development of these conditions.